The World Market for Streptomycins, Derivatives, and Salts: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for streptomycins, derivatives, and salts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for streptomycins, derivatives, and salts for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Streptomycins, derivatives, and salts" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "streptomycins, derivatives, and salts" is 54132.
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: STREPTOMYCINS, DERIVATIVES, AND SALTS EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 SOUTH AFRICA
3.2 ASIA: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 INDIA
3.2.4 JAPAN
3.2.5 SINGAPORE
3.2.6 SOUTH KOREA
3.3 EUROPE: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 BELGIUM
3.3.3 BULGARIA
3.3.4 DENMARK
3.3.5 FRANCE
3.3.6 GERMANY
3.3.7 IRELAND
3.3.8 ITALY
3.3.9 LITHUANIA
3.3.10 ROMANIA
3.3.11 RUSSIA
3.3.12 SPAIN
3.3.13 SWITZERLAND
3.3.14 THE CZECH REPUBLIC
3.3.15 THE NETHERLANDS
3.3.16 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 MEXICO
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 THE UNITED STATES
3.6 THE MIDDLE EAST: EXPORT SUPPLIES OF STREPTOMYCINS, DERIVATIVES, AND SALTS IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 IRAN
4 IMPORTS
4.1 AFRICA: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 EGYPT
4.1.3 MOROCCO
4.1.4 SOUTH AFRICA
4.2 ASIA: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 INDIA
4.2.3 INDONESIA
4.2.4 JAPAN
4.2.5 MALAYSIA
4.2.6 NEPAL
4.2.7 SINGAPORE
4.2.8 SOUTH KOREA
4.2.9 TAIWAN
4.2.10 THAILAND
4.2.11 THE PHILIPPINES
4.2.12 VIETNAM
4.3 EUROPE: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BULGARIA
4.3.6 CROATIA
4.3.7 DENMARK
4.3.8 ESTONIA
4.3.9 FRANCE
4.3.10 GERMANY
4.3.11 GREECE
4.3.12 HUNGARY
4.3.13 IRELAND
4.3.14 ITALY
4.3.15 KAZAKHSTAN
4.3.16 MOLDOVA
4.3.17 NORWAY
4.3.18 POLAND
4.3.19 ROMANIA
4.3.20 RUSSIA
4.3.21 SPAIN
4.3.22 THE NETHERLANDS
4.3.23 THE UNITED KINGDOM
4.3.24 UKRAINE
4.4 LATIN AMERICA: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 COLOMBIA
4.4.6 ECUADOR
4.4.7 EL SALVADOR
4.4.8 MEXICO
4.4.9 PARAGUAY
4.4.10 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 THE DOMINICAN REPUBLIC
4.5.4 THE UNITED STATES
4.6 OCEANIA: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: STREPTOMYCINS, DERIVATIVES, AND SALTS IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 JORDAN
4.7.3 PAKISTAN
4.7.4 TURKEY
4.7.5 YEMEN
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS